News & Perspective

May 28, 2004

May 28, 2004

NIAID seeks vaccines for H5N1 avian flu

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) said yesterday it has awarded contracts to two companies to develop vaccines based on the H5N1 avian influenza virus in an effort to limit the risk of a human influenza pandemic.

Dec 03, 2004

Dec 03, 2004

Departing HHS chief cites pandemic flu, food tampering as top concerns

(CIDRAP News) – In announcing his resignation today after 4 years as US Health and Human services (HHS) secretary, Tommy G. Thompson cited pandemic influenza and food biosecurity as two of his biggest worries.

Thompson, who presided over massive increases in federal spending for public health preparedness and biodefense research, said in response to a question, "There are two things that really worry me yet. The big one is pandemic flu."

Jun 27, 2005

Jun 27, 2005

Momentum builds for cell-culture flu vaccines

(CIDRAP News) – You've got to gather a lot of eggs to supply the world with influenza vaccine, but that might change before long.

Sep 28, 2005

Sep 28, 2005

NIAID, MedImmune team up to develop pandemic flu vaccines

(CIDRAP News) – The federal government and MedImmune Inc. announced today they will collaborate to develop vaccines for potential pandemic strains of influenza, using the technology that was used to create the company's nasal-spray flu vaccine, FluMist.

Jun 02, 2006

Jun 02, 2006

Flu vaccine makers get HHS funds to prepare for pandemic

Jun 20, 2007 (CIDRAP News) – Federal health officials last week announced the awarding of contracts totaling $132.5 million to help two vaccine producers get ready to start churning out vaccines in the event of a flu pandemic.

Jul 05, 2006

Jul 05, 2006

HHS has enough H5N1 vaccine for 4 million people

(CIDRAP News) – In an update on pandemic influenza preparedness efforts, the federal government said last week it had stockpiled enough vaccine against H5N1 avian influenza virus to inoculate about 4 million people and enough antiviral medication to treat about 6.3 million.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Jul 21, 2006

Jul 21, 2006

HHS adds Relenza to state stockpile program

(CIDRAP News) – The US Department of Health and Human Services (HHS) yesterday announced a contract with GlaxoSmithKline (GSK) that will allow states to add the influenza drug zanamivir (Relenza) to their federally subsidized antiviral stockpiles.

Sep 08, 2006

Sep 08, 2006

Could blood from H5N1 flu survivors help others?

(CIDRAP News) – A recent report about the use of blood products to treat patients in the Spanish influenza pandemic of 1918 has sparked interest among those concerned about the threat of the next pandemic, but experts say it's far from clear whether the approach would be practicable in a pandemic today.

Oct 04, 2006

Oct 04, 2006

Groups call for pandemic flu vaccine 'master plan'

(CIDRAP News) – Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»